Dynavax withdraws EU marketing application for Hep B vaccine
February 18, 2014 at 10:00 AM EST
Feb 18 (Reuters) - Dynavax Technologies Corp said it had withdrawn a European marketing application for its experimental hepatitis B vaccine due to safety concerns raised by the European Medicines Agency.
